High-dose therapy may also cause a brief increase in blood pressure, though this usually returns to baseline within a few hours
Leibson CL, Hall Lon K, Ransom JE, et al
In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
All compounds verified to 99%+ purity, USA manufactured
an appropriate solute must be added first
BPC-157 has shown promise for promoting healing in musculoskeletal injuries such as fractures, tendon ruptures, ligament tears, and muscle injuries, and plays a role in promoting cell growth, cell tissue regeneration, and collagen synthesis